FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncology, namely to the use of bisimidazole-(1,10)-phenanthroline of copper (II) dichloride of the formula given below, as an agent possessing radiosensitizing activity.
EFFECT: wider range of agents possessing radiosensitizing activity.
1 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TUMOUR CELL RADIOSENSITIZATION METHOD | 2024 |
|
RU2834199C1 |
| IMMUNOSUPPRESSANT | 2011 |
|
RU2448696C1 |
| DI[(FURAN-3-CARBOXYLATE-O)-(2,9-DIMETHYL-1,10-PHENANTHROLINE-N,N')-COPPER(II)] WITH ANTIPROLIFERATIVE AND ANTIMYCOBACTERIAL ACTIVITY | 2023 |
|
RU2815425C1 |
| BIS-IMIDAZOLE-(1,10)-PHENANTHROLINE COPPER (II) DICHLORIDE SHOWING ANTIBACTERIAL AND ANTIBLASTIC ACTIVITY, METHOD OF ITS SYNTHESIS | 2001 |
|
RU2190616C1 |
| MEANS WITH RADIO SENSITIZING EFFECT | 2021 |
|
RU2763884C1 |
| METHOD FOR ENHANCING TUMOR CELL DEATH IN COMBINATION OF IONIZING RADIATION AND CDK INHIBITOR | 2020 |
|
RU2777869C2 |
| PHOTOSENSITIZER FOR PHOTODYNAMIC DESTRUCTION OF TUMOR CELLS | 2023 |
|
RU2805148C1 |
| SENSITIZER FOR PHOTODYNAMIC DESTRUCTION OF TUMOR CELLS | 2021 |
|
RU2771237C1 |
| RADIOSENSITIZER | 2019 |
|
RU2720455C1 |
| BISIMIDAZOLE-(1,10)-PHENENTHROLINE PLATINUM (III) DICHLORIDE SHOWING CYTOSTATIC ANTITUMOR ACTIVITY | 1995 |
|
RU2089555C1 |
